USHBP1
gene geneOn this page
Also known as MCC2AIEBPFLJ38709
Summary
USHBP1 (USH1 protein network component harmonin binding protein 1, HGNC:24058) is a protein-coding gene on chromosome 19p13.11, encoding Harmonin-binding protein USHBP1 (Q8N6Y0).
Enables PDZ domain binding activity.
Source: NCBI Gene 83878 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 144 total
- MANE Select transcript:
NM_031941
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24058 |
| Approved symbol | USHBP1 |
| Name | USH1 protein network component harmonin binding protein 1 |
| Location | 19p13.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MCC2, AIEBP, FLJ38709 |
| Ensembl gene | ENSG00000130307 |
| Ensembl biotype | protein_coding |
| OMIM | 611810 |
| Entrez | 83878 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 7 protein_coding, 2 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined, 2 retained_intron
ENST00000252597, ENST00000324554, ENST00000431146, ENST00000594190, ENST00000595993, ENST00000596436, ENST00000597928, ENST00000598309, ENST00000598570, ENST00000600286, ENST00000881047, ENST00000881048, ENST00000965831
RefSeq mRNA: 3 — MANE Select: NM_031941
NM_001297703, NM_001321417, NM_031941
CCDS: CCDS12353, CCDS77256
Canonical transcript exons
ENST00000252597 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000895475 | 17262552 | 17262990 |
| ENSE00003048589 | 17264671 | 17264745 |
| ENSE00003143629 | 17249171 | 17250414 |
| ENSE00003540814 | 17258212 | 17258385 |
| ENSE00003557108 | 17259289 | 17259429 |
| ENSE00003591104 | 17259897 | 17260022 |
| ENSE00003594303 | 17251911 | 17252017 |
| ENSE00003622312 | 17264002 | 17264150 |
| ENSE00003629062 | 17259596 | 17259732 |
| ENSE00003633357 | 17251582 | 17251704 |
| ENSE00003633360 | 17264246 | 17264347 |
| ENSE00003675306 | 17255385 | 17255606 |
| ENSE00003675641 | 17256471 | 17256720 |
Expression profiles
Bgee: expression breadth ubiquitous, 164 present calls, max score 92.32.
FANTOM5 (CAGE): breadth broad, TPM avg 1.1417 / max 68.5114, expressed in 343 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 179848 | 1.0320 | 331 |
| 179847 | 0.1097 | 60 |
Top tissues by expression
245 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| apex of heart | UBERON:0002098 | 92.32 | gold quality |
| sural nerve | UBERON:0015488 | 85.56 | gold quality |
| right lung | UBERON:0002167 | 84.03 | gold quality |
| heart left ventricle | UBERON:0002084 | 83.54 | gold quality |
| cardiac ventricle | UBERON:0002082 | 82.96 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 81.92 | gold quality |
| omental fat pad | UBERON:0010414 | 81.77 | gold quality |
| peritoneum | UBERON:0002358 | 81.70 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 81.21 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 81.09 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 80.52 | gold quality |
| buccal mucosa cell | CL:0002336 | 80.24 | silver quality |
| body of uterus | UBERON:0009853 | 79.00 | gold quality |
| heart | UBERON:0000948 | 78.67 | gold quality |
| upper lobe of lung | UBERON:0008948 | 78.55 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 78.41 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 78.38 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 78.22 | gold quality |
| mucosa of stomach | UBERON:0001199 | 78.11 | gold quality |
| adipose tissue | UBERON:0001013 | 78.01 | gold quality |
| metanephros cortex | UBERON:0010533 | 77.42 | gold quality |
| right atrium auricular region | UBERON:0006631 | 77.36 | gold quality |
| cardiac atrium | UBERON:0002081 | 77.00 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.74 | silver quality |
| left lobe of thyroid gland | UBERON:0001120 | 76.43 | gold quality |
| gastrocnemius | UBERON:0001388 | 76.33 | gold quality |
| muscle of leg | UBERON:0001383 | 76.27 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 76.20 | gold quality |
| lower esophagus | UBERON:0013473 | 76.15 | gold quality |
| thyroid gland | UBERON:0002046 | 75.93 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.52 |
| E-GEOD-106540 | no | 59.84 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
3 targeting USHBP1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-198 | 98.70 | 67.32 | 920 |
| HSA-MIR-5699-5P | 97.36 | 67.03 | 1014 |
| HSA-MIR-668-3P | 96.18 | 65.80 | 673 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ushbp1 | ENSDARG00000089071 |
| mus_musculus | Ushbp1 | ENSMUSG00000034911 |
| rattus_norvegicus | Ushbp1 | ENSRNOG00000023485 |
| drosophila_melanogaster | CG34404 | FBGN0085433 |
Paralogs (1): MCC (ENSG00000171444)
Protein
Protein identifiers
Harmonin-binding protein USHBP1 — Q8N6Y0 (reviewed: Q8N6Y0)
Alternative names: AIE-75-binding protein, Mutated in colon cancer protein 2, Usher syndrome type-1C protein-binding protein 1
All UniProt accessions (5): Q8N6Y0, G8JLM4, M0R172, M0R3B1, Q8N8Y1
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Interacts via its C-terminus with the first PDZ domain of USH1C.
Tissue specificity. Highest level of expression in heart, and moderate to low expression in skeletal muscle, kidney, liver, small intestine, placenta and lung.
Miscellaneous. Due to the retention of an intron in the cDNA leading to a prematurate stop codon.
Similarity. Belongs to the MCC family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N6Y0-1 | 1 | yes |
| Q8N6Y0-2 | 2 |
RefSeq proteins (3): NP_001284632, NP_001308346, NP_114147* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR019536 | USHBP1_PDZ-bd | Domain |
| IPR040171 | USBP1-like | Family |
Pfam: PF10506
UniProt features (23 total): sequence conflict 6, region of interest 5, coiled-coil region 4, compositionally biased region 3, sequence variant 3, chain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N6Y0-F1 | 69.48 | 0.37 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 47 (showing top):
MARTINEZ_RB1_TARGETS_DN, NIKOLSKY_BREAST_CANCER_19P13_AMPLICON, RYTTCCTG_ETS2_B, MODULE_397, MARTINEZ_RB1_AND_TP53_TARGETS_UP, chr19p13, IGLV5_37_TARGET_GENES, NFKBIA_TARGET_GENES, TFEB_TARGET_GENES, ZNF768_TARGET_GENES, ZSCAN31_TARGET_GENES, GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_DN, MODULE_486, GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_DN, GSE17721_CTRL_VS_LPS_4H_BMDC_DN
GO Biological Process (0):
GO Molecular Function (2): PDZ domain binding (GO:0030165), protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein domain specific binding | 1 |
| binding | 1 |
Protein interactions and networks
STRING
702 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| USHBP1 | MCCC2 | Q9HCC0 | 960 |
| USHBP1 | E9PNW1 | E9PNW1 | 908 |
| USHBP1 | BTD | P43251 | 810 |
| USHBP1 | MCCC1 | Q96RQ3 | 603 |
| USHBP1 | ZMAT4 | Q9H898 | 535 |
| USHBP1 | GMCL1 | Q96IK5 | 510 |
| USHBP1 | ZBTB25 | P24278 | 487 |
| USHBP1 | BABAM1 | Q9NWV8 | 446 |
| USHBP1 | MCC | P23508 | 414 |
| USHBP1 | ABHD8 | Q96I13 | 397 |
| USHBP1 | RFTN1 | Q14699 | 376 |
| USHBP1 | KPNA1 | P52294 | 371 |
| USHBP1 | MAGEA11 | P43364 | 338 |
| USHBP1 | FIBIN | Q8TAL6 | 335 |
| USHBP1 | MMRN2 | Q9H8L6 | 335 |
IntAct
850 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DYDC1 | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| USHBP1 | C1orf216 | psi-mi:“MI:0915”(physical association) | 0.780 |
| COPS4 | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| C1orf216 | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| USHBP1 | COPS4 | psi-mi:“MI:0915”(physical association) | 0.780 |
| MAGEB4 | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| MOS | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| USHBP1 | TXLNA | psi-mi:“MI:0915”(physical association) | 0.720 |
| SYNJ2BP | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| BEX3 | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| USHBP1 | KLHL38 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TXLNB | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| CENPP | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| CCDC116 | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| USHBP1 | CCDC24 | psi-mi:“MI:0915”(physical association) | 0.720 |
| USHBP1 | KRT38 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TRIM54 | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| USHBP1 | MED4 | psi-mi:“MI:0915”(physical association) | 0.720 |
| CCHCR1 | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| MCRS1 | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| USHBP1 | ZFYVE26 | psi-mi:“MI:0915”(physical association) | 0.720 |
| FAM110A | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| USHBP1 | PARVG | psi-mi:“MI:0915”(physical association) | 0.720 |
| USHBP1 | IMP3 | psi-mi:“MI:0915”(physical association) | 0.720 |
| USHBP1 | SEC14L4 | psi-mi:“MI:0915”(physical association) | 0.720 |
| VPS28 | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| USHBP1 | MAGEB4 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TXLNA | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
BioGRID (315): USHBP1 (Two-hybrid), USHBP1 (Two-hybrid), USHBP1 (Two-hybrid), USHBP1 (Two-hybrid), USHBP1 (Two-hybrid), USHBP1 (Two-hybrid), USHBP1 (Two-hybrid), USHBP1 (Two-hybrid), USHBP1 (Two-hybrid), USHBP1 (Two-hybrid), USHBP1 (Two-hybrid), USHBP1 (Two-hybrid), USHBP1 (Two-hybrid), USHBP1 (Two-hybrid), USHBP1 (Two-hybrid)
ESM2 similar proteins: A0A140LIT1, A0A1B0GVG4, A0JNH6, A1A5D9, A6NC98, A6NGB0, A6NJZ7, A6NNM3, F6XLV1, O15049, O54887, P0C7N4, P58660, P60531, Q0D2H9, Q0P5D1, Q2KJ21, Q2TAC2, Q3LUD3, Q3T1I3, Q3TMW1, Q3V0F0, Q4QRL3, Q5JTB6, Q5RD60, Q66HR5, Q6NSJ2, Q6PHN1, Q6QZQ4, Q80VM7, Q8BP01, Q8C7U1, Q8CB62, Q8CGU1, Q8CHW5, Q8K2I2, Q8N137, Q8N283, Q8N6Y0, Q8R370
Diamond homologs: Q3T1I3, Q8N6Y0, Q8R370
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 88 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| intermediate filament organization | 5 | 16.5× | 4e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
144 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 122 |
| Likely benign | 14 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4331 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:17250275:T:TA | donor_gain | 1.0000 |
| 19:17250276:C:A | donor_gain | 1.0000 |
| 19:17250280:AGGGC:A | donor_gain | 1.0000 |
| 19:17250313:T:TA | donor_gain | 1.0000 |
| 19:17250410:GGGCG:G | acceptor_gain | 1.0000 |
| 19:17250411:GGCG:G | acceptor_gain | 1.0000 |
| 19:17250412:GCG:G | acceptor_gain | 1.0000 |
| 19:17250412:GCGC:G | acceptor_loss | 1.0000 |
| 19:17250413:CG:C | acceptor_gain | 1.0000 |
| 19:17250413:CGC:C | acceptor_gain | 1.0000 |
| 19:17250413:CGCTG:C | acceptor_loss | 1.0000 |
| 19:17250414:GCTG:G | acceptor_loss | 1.0000 |
| 19:17250415:C:CC | acceptor_gain | 1.0000 |
| 19:17251576:TCCTA:T | donor_loss | 1.0000 |
| 19:17251577:CCTAC:C | donor_loss | 1.0000 |
| 19:17251578:CTAC:C | donor_loss | 1.0000 |
| 19:17251578:CTACC:C | donor_loss | 1.0000 |
| 19:17251579:TACC:T | donor_loss | 1.0000 |
| 19:17251579:TACCT:T | donor_loss | 1.0000 |
| 19:17251580:A:AC | donor_gain | 1.0000 |
| 19:17251580:A:T | donor_loss | 1.0000 |
| 19:17251580:ACCTG:A | donor_loss | 1.0000 |
| 19:17251581:C:CC | donor_gain | 1.0000 |
| 19:17251597:AAATC:A | donor_gain | 1.0000 |
| 19:17251601:C:A | donor_gain | 1.0000 |
| 19:17251700:GTGTC:G | acceptor_gain | 1.0000 |
| 19:17251701:TGTC:T | acceptor_gain | 1.0000 |
| 19:17251702:GTC:G | acceptor_gain | 1.0000 |
| 19:17251702:GTCCT:G | acceptor_loss | 1.0000 |
| 19:17251703:TC:T | acceptor_gain | 1.0000 |
AlphaMissense
4516 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:17259369:C:A | K322N | 0.958 |
| 19:17259369:C:G | K322N | 0.958 |
| 19:17259415:A:G | L307P | 0.954 |
| 19:17264270:G:C | S10R | 0.947 |
| 19:17264270:G:T | S10R | 0.947 |
| 19:17264272:T:G | S10R | 0.947 |
| 19:17262837:A:C | F119L | 0.944 |
| 19:17262837:A:T | F119L | 0.944 |
| 19:17262839:A:G | F119L | 0.944 |
| 19:17262646:A:G | L183P | 0.943 |
| 19:17259394:A:G | L314P | 0.935 |
| 19:17259382:A:G | L318P | 0.933 |
| 19:17259348:G:C | S329R | 0.932 |
| 19:17259348:G:T | S329R | 0.932 |
| 19:17259350:T:G | S329R | 0.932 |
| 19:17259402:A:C | N311K | 0.931 |
| 19:17259402:A:T | N311K | 0.931 |
| 19:17259326:C:G | A337P | 0.922 |
| 19:17259304:A:G | L344P | 0.909 |
| 19:17264124:A:C | S27R | 0.907 |
| 19:17264124:A:T | S27R | 0.907 |
| 19:17264126:T:G | S27R | 0.907 |
| 19:17259397:A:G | L313P | 0.904 |
| 19:17255542:A:G | L512P | 0.899 |
| 19:17260012:A:G | L218P | 0.896 |
| 19:17259320:C:G | A339P | 0.892 |
| 19:17255485:A:G | L531P | 0.889 |
| 19:17256496:A:G | I482T | 0.889 |
| 19:17259302:C:G | A345P | 0.880 |
| 19:17250409:A:G | L643P | 0.879 |
dbSNP variants (sampled 300 via entrez): RS1000166186 (19:17256001 TCAAA>T), RS1000304838 (19:17251188 T>A,C,G), RS1000467902 (19:17266444 G>A,C), RS1000553602 (19:17260805 G>C), RS1001177979 (19:17255293 A>C), RS1001190141 (19:17266249 G>A,T), RS1001244532 (19:17259974 G>A), RS1001445109 (19:17254823 G>A), RS1001499308 (19:17265995 C>A), RS1001609572 (19:17256786 A>G), RS1001827974 (19:17265900 C>A,T), RS1002344665 (19:17261141 C>A), RS1002429046 (19:17253087 G>C), RS1002657787 (19:17257845 C>T), RS1002719897 (19:17258963 C>T)
Disease associations
OMIM: gene MIM:611810 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007394_2 | Mitochondrial DNA copy number | 1.000000e-14 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006312 | mitochondrial DNA measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| aflatoxin B2 | increases methylation | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | decreases methylation | 1 |
| Azacitidine | decreases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Valproic Acid | increases methylation | 1 |
| 8-Bromo Cyclic Adenosine Monophosphate | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Particulate Matter | increases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.